المؤلفون: Sabet FS; Department of Nanobiotechnology, Faculty of Biological Science, Tarbiat Modares University, Tehran, Iran. Electronic address: fereshte.sabet@modares.ac.ir., Dabirmanesh B; Department of Biochemistry, Faculty of Biological Science, Tarbiat Modares University, Tehran, Iran. Electronic address: dabirmanesh@modares.ac.ir., Sabet HS; Department of Life Science Engineering, Faculty of New Sciences & Technologies, University of Tehran, Tehran, Iran. Electronic address: hoorie.sabet@ut.ac.ir., Zarei P; Department of Physiology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran. Electronic address: Parisa.zareie@modares.ac.ir., Hosseini M; Department of Life Science Engineering, Faculty of New Sciences & Technologies, University of Tehran, Tehran, Iran. Electronic address: hosseini_m@ut.ac.ir., Fathollahi Y; Department of Physiology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran. Electronic address: fatolahi@modares.ac.ir., Khajeh K; Department of Nanobiotechnology, Faculty of Biological Science, Tarbiat Modares University, Tehran, Iran; Department of Biochemistry, Faculty of Biological Science, Tarbiat Modares University, Tehran, Iran. Electronic address: khajeh@modares.ac.ir.

المصدر: International journal of pharmaceutics [Int J Pharm] 2024 Oct 25; Vol. 664, pp. 124610. Date of Electronic Publication: 2024 Aug 20.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 7804127 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3476 (Electronic) Linking ISSN: 03785173 NLM ISO Abbreviation: Int J Pharm Subsets: MEDLINE

مواضيع طبية MeSH: Anticonvulsants*/administration & dosage , Anticonvulsants*/chemistry , Carbamazepine*/administration & dosage , Carbamazepine*/chemistry , Carbamazepine*/pharmacokinetics , Liposomes* , Epilepsy*/drug therapy , Drug Delivery Systems*, Animals ; Male ; Drug Liberation ; Rats, Sprague-Dawley ; Rats ; Hippocampus/drug effects ; Nanoparticles/administration & dosage ; Nanoparticles/chemistry ; Metallocenes/chemistry ; Metallocenes/administration & dosage ; Ferrous Compounds/administration & dosage ; Ferrous Compounds/chemistry ; Electric Stimulation ; Kindling, Neurologic/drug effects ; Particle Size ; Seizures/drug therapy

المؤلفون: Sá Filho A; Graduate Program in Pharmaceutical Sciences, Evangelical University of Goiás, Anapolis 75083-515, GO, Brazil., Martins JLR; Graduate Program in Pharmaceutical Sciences, Evangelical University of Goiás, Anapolis 75083-515, GO, Brazil., Costa RF; Graduate Program in Pharmaceutical Sciences, Evangelical University of Goiás, Anapolis 75083-515, GO, Brazil., Pedrino GR; Institute of Biological Sciences, Federal University of Goiás, Goiás 74605-010, GO, Brazil., Duarte VS; Structural and Theoretical Chemistry Group, State University of Goiás, Anápolis 75083-515, GO, Brazil., Silva ON; Graduate Program in Pharmaceutical Sciences, Evangelical University of Goiás, Anapolis 75083-515, GO, Brazil., Napolitano HB; Graduate Program in Pharmaceutical Sciences, Evangelical University of Goiás, Anapolis 75083-515, GO, Brazil.; Structural and Theoretical Chemistry Group, State University of Goiás, Anápolis 75083-515, GO, Brazil., Fajemiroye JO; Graduate Program in Pharmaceutical Sciences, Evangelical University of Goiás, Anapolis 75083-515, GO, Brazil.; Institute of Biological Sciences, Federal University of Goiás, Goiás 74605-010, GO, Brazil.

المصدر: International journal of molecular sciences [Int J Mol Sci] 2024 Sep 11; Vol. 25 (18). Date of Electronic Publication: 2024 Sep 11.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

مواضيع طبية MeSH: Carbamazepine*/pharmacology , Carbamazepine*/analogs & derivatives , Anticonvulsants*/pharmacology, Animals ; Mice ; Seizures/drug therapy ; Seizures/chemically induced ; Neurons/drug effects ; Neurons/metabolism ; Oxcarbazepine/pharmacology ; Diazepam/pharmacology ; Male ; Pentylenetetrazole ; Cell Survival/drug effects ; Topiramate/pharmacology ; Barbiturates/pharmacology

المؤلفون: Harris K; Clinical Toxicology Unit, Princess Alexandra Hospital, Brisbane, Australia.; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.; Queensland Poisons Information Centre, Queensland Children's Hospital, Brisbane, Queensland, Australia., Dalton B; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.; Queensland Poisons Information Centre, Queensland Children's Hospital, Brisbane, Queensland, Australia., Learmont BG; Clinical Toxicology Unit, Princess Alexandra Hospital, Brisbane, Australia., Isoardi KZ; Clinical Toxicology Unit, Princess Alexandra Hospital, Brisbane, Australia.; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.; Queensland Poisons Information Centre, Queensland Children's Hospital, Brisbane, Queensland, Australia.

المصدر: Clinical toxicology (Philadelphia, Pa.) [Clin Toxicol (Phila)] 2024 Aug; Vol. 62 (8), pp. 533-535. Date of Electronic Publication: 2024 Aug 20.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 101241654 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-9519 (Electronic) Linking ISSN: 15563650 NLM ISO Abbreviation: Clin Toxicol (Phila) Subsets: MEDLINE

مواضيع طبية MeSH: Carbamazepine*/poisoning , Carbamazepine*/administration & dosage , Seizures*/chemically induced , Drug Overdose* , Dose-Response Relationship, Drug* , Anticonvulsants*/poisoning , Anticonvulsants*/administration & dosage , Hypotension*/chemically induced, Humans ; Retrospective Studies ; Male ; Female ; Adult ; Middle Aged ; Young Adult ; Poison Control Centers/statistics & numerical data ; Coma/chemically induced ; Adolescent ; Aged

عنوان ترانسليتريتد: Medikamentöse Therapie der Trigeminusneuralgie : Die neue Leitlinie.

المؤلفون: Ruscheweyh R; Neurologische Klinik und Poliklinik, LMU Klinikum, LMU München, Marchioninistr. 15, 81377, München, Deutschland. ruth.ruscheweyh@med.uni-muenchen.de., Gierthmühlen J; Interdisziplinäres Zentrum für Schmerz- und Palliativmedizin, Klinik für Anästhesiologie und Operative Intensivmedizin, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Kiel, Deutschland., Hedderich DM; Abteilung für Diagnostische und Interventionelle Neuroradiologie, Klinikum rechts der Isar, School of Medicine and Health, Technische Universität München, München, Deutschland., Goßrau G; Kopfschmerzambulanz, Interdisziplinäres UniversitätsSchmerzCentrum, Medizinische Fakultät, Universitätsklinikum Dresden, TU Dresden, Dresden, Deutschland., Leis S; Christian-Doppler-Klinik, Universitätsklinik für Neurologie, neurologische Intensivmedizin und Neurorehabilitation, Paracelsus Medizinische Universität, Salzburg, Österreich.

المصدر: Schmerz (Berlin, Germany) [Schmerz] 2024 Aug; Vol. 38 (4), pp. 283-292. Date of Electronic Publication: 2024 Apr 30.

نوع المنشور: English Abstract; Journal Article

بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 8906258 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-2129 (Electronic) Linking ISSN: 0932433X NLM ISO Abbreviation: Schmerz Subsets: MEDLINE

مواضيع طبية MeSH: Carbamazepine*/therapeutic use , Carbamazepine*/adverse effects , Phenytoin*/therapeutic use , Phenytoin*/adverse effects , Trigeminal Neuralgia*/drug therapy , Trigeminal Neuralgia*/diagnosis, Humans ; Anticonvulsants/therapeutic use ; Anticonvulsants/adverse effects ; Cooperative Behavior ; Diagnosis, Differential ; Germany ; Guideline Adherence ; Interdisciplinary Communication ; Intersectoral Collaboration ; Off-Label Use ; Practice Guidelines as Topic

المؤلفون: Jaiprasart P; Clinical Pharmacology & Pharmacometrics, Janssen Research & Development, North Wales, PA, USA., Hellemans P; Oncology Research & Development, Janssen Research & Development, Beerse, Belgium., Jiao JJ; Statistics and Decision Science, Janssen Research & Development, Raritan, NJ, USA., Dosne AG; Clinical Pharmacology & Pharmacometrics, Janssen Research & Development, Beerse, Belgium., De Meulder M; Bioanalytical Discovery & Development Sciences, Janssen Research & Development, Beerse, Belgium., De Zwart L; Preclinical Sciences & Translational Safety, Janssen Research & Development, Beerse, Belgium., Brees L; Clinical Pharmacology Unit, Janssen Research & Development, Merksem, Belgium., Zhu W; Clinical Pharmacology & Pharmacometrics, Janssen Research & Development, Raritan, NJ, USA.

المصدر: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2024 Aug; Vol. 13 (8), pp. 852-860. Date of Electronic Publication: 2024 May 13.

نوع المنشور: Journal Article; Clinical Trial, Phase I

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2160-7648 (Electronic) Linking ISSN: 2160763X NLM ISO Abbreviation: Clin Pharmacol Drug Dev Subsets: MEDLINE

مواضيع طبية MeSH: Drug Interactions* , Healthy Volunteers* , Carbamazepine*/pharmacology , Carbamazepine*/pharmacokinetics , Carbamazepine*/administration & dosage , Area Under Curve* , Cytochrome P-450 CYP3A*/metabolism, Humans ; Adult ; Male ; Female ; Young Adult ; Middle Aged ; Cytochrome P-450 CYP3A Inducers/pharmacology ; Cytochrome P-450 CYP2C9/metabolism ; Pyrazoles/pharmacokinetics ; Pyrazoles/adverse effects ; Pyrazoles/administration & dosage ; Pyrazoles/pharmacology ; Quinoxalines/pharmacokinetics ; Quinoxalines/adverse effects ; Quinoxalines/administration & dosage ; Quinoxalines/pharmacology ; Administration, Oral ; Receptors, Fibroblast Growth Factor/antagonists & inhibitors

المؤلفون: Lukic V; National Poison Control Centre, Military Medical Academy, Belgrade, Serbia.; Medical Faculty of the Military Medical Academy, University of Defence, Belgrade, Serbia., Jankovic SM; Department of Pharmacology and Toxicology, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.; Department of Clinical Pharmacology, University Clinical Center Kragujevac, Kragujevac, Serbia., Petrovic NZ; Department of Pharmacology and Toxicology, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.; Department of Clinical Pharmacology, University Clinical Center Kragujevac, Kragujevac, Serbia., Vucinic S; National Poison Control Centre, Military Medical Academy, Belgrade, Serbia.; Medical Faculty of the Military Medical Academy, University of Defence, Belgrade, Serbia., Jovic Stosic J; National Poison Control Centre, Military Medical Academy, Belgrade, Serbia.; Medical Faculty of the Military Medical Academy, University of Defence, Belgrade, Serbia., Djordjevic S; National Poison Control Centre, Military Medical Academy, Belgrade, Serbia.; Medical Faculty of the Military Medical Academy, University of Defence, Belgrade, Serbia., Dragojevic-Simić V; Medical Faculty of the Military Medical Academy, University of Defence, Belgrade, Serbia.; Centre for Clinical Pharmacology, Military Medical Academy, Belgrade, Serbia.

المصدر: Expert opinion on drug metabolism & toxicology [Expert Opin Drug Metab Toxicol] 2024 Aug; Vol. 20 (8), pp. 817-825. Date of Electronic Publication: 2024 Jul 21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 101228422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7607 (Electronic) Linking ISSN: 17425255 NLM ISO Abbreviation: Expert Opin Drug Metab Toxicol Subsets: MEDLINE

مواضيع طبية MeSH: Carbamazepine*/pharmacokinetics , Carbamazepine*/administration & dosage , Carbamazepine*/toxicity , Carbamazepine*/analogs & derivatives , Anticonvulsants*/pharmacokinetics , Anticonvulsants*/administration & dosage , Anticonvulsants*/toxicity , Toxicokinetics*, Humans ; Adult ; Male ; Female ; Middle Aged ; Models, Biological ; Drug Overdose ; Young Adult ; Software ; Aged

المؤلفون: Barnard SN; From the Department of Neuroscience (S.N.B., Z.C., P.P.), Central Clinical School, and Clinical Epidemiology (Z.C.), School of Public Health and Preventive Medicine, Monash University; Department of Neurology (S.N.B., Z.C., P.P.), Alfred Health, Melbourne, Australia; Department of Neurology (S.N.B., J.F.), New York University Grossman School of Medicine, New York; Department of Neurology (A.M.K.), University of Miami, Miller School of Medicine, FL; Department of Neurology (M.G.H.), Westchester Medical Center Health, Valhalla, NY; Mid-Atlantic Epilepsy and Sleep Center (P.K.), Bethesda, MD; Department of Neurology (P.K.), The George Washington University, DC; Department of Neurology (B.W.A.-K.), Vanderbilt University Medical Center, Nashville, TN; School of Pharmacy (B.E.G.), University of Wisconsin, Madison; Department of Neurology (P.P.), The Royal Melbourne Hospital; Department of Medicine (P.P.), Austin Health, The University of Melbourne; and Bladin-Berkovic Comprehensive Epilepsy Program (P.P.), Department of Neurology, Austin Health, Heidelberg, Australia., Chen Z; From the Department of Neuroscience (S.N.B., Z.C., P.P.), Central Clinical School, and Clinical Epidemiology (Z.C.), School of Public Health and Preventive Medicine, Monash University; Department of Neurology (S.N.B., Z.C., P.P.), Alfred Health, Melbourne, Australia; Department of Neurology (S.N.B., J.F.), New York University Grossman School of Medicine, New York; Department of Neurology (A.M.K.), University of Miami, Miller School of Medicine, FL; Department of Neurology (M.G.H.), Westchester Medical Center Health, Valhalla, NY; Mid-Atlantic Epilepsy and Sleep Center (P.K.), Bethesda, MD; Department of Neurology (P.K.), The George Washington University, DC; Department of Neurology (B.W.A.-K.), Vanderbilt University Medical Center, Nashville, TN; School of Pharmacy (B.E.G.), University of Wisconsin, Madison; Department of Neurology (P.P.), The Royal Melbourne Hospital; Department of Medicine (P.P.), Austin Health, The University of Melbourne; and Bladin-Berkovic Comprehensive Epilepsy Program (P.P.), Department of Neurology, Austin Health, Heidelberg, Australia., Kanner AM; From the Department of Neuroscience (S.N.B., Z.C., P.P.), Central Clinical School, and Clinical Epidemiology (Z.C.), School of Public Health and Preventive Medicine, Monash University; Department of Neurology (S.N.B., Z.C., P.P.), Alfred Health, Melbourne, Australia; Department of Neurology (S.N.B., J.F.), New York University Grossman School of Medicine, New York; Department of Neurology (A.M.K.), University of Miami, Miller School of Medicine, FL; Department of Neurology (M.G.H.), Westchester Medical Center Health, Valhalla, NY; Mid-Atlantic Epilepsy and Sleep Center (P.K.), Bethesda, MD; Department of Neurology (P.K.), The George Washington University, DC; Department of Neurology (B.W.A.-K.), Vanderbilt University Medical Center, Nashville, TN; School of Pharmacy (B.E.G.), University of Wisconsin, Madison; Department of Neurology (P.P.), The Royal Melbourne Hospital; Department of Medicine (P.P.), Austin Health, The University of Melbourne; and Bladin-Berkovic Comprehensive Epilepsy Program (P.P.), Department of Neurology, Austin Health, Heidelberg, Australia., Holmes MG; From the Department of Neuroscience (S.N.B., Z.C., P.P.), Central Clinical School, and Clinical Epidemiology (Z.C.), School of Public Health and Preventive Medicine, Monash University; Department of Neurology (S.N.B., Z.C., P.P.), Alfred Health, Melbourne, Australia; Department of Neurology (S.N.B., J.F.), New York University Grossman School of Medicine, New York; Department of Neurology (A.M.K.), University of Miami, Miller School of Medicine, FL; Department of Neurology (M.G.H.), Westchester Medical Center Health, Valhalla, NY; Mid-Atlantic Epilepsy and Sleep Center (P.K.), Bethesda, MD; Department of Neurology (P.K.), The George Washington University, DC; Department of Neurology (B.W.A.-K.), Vanderbilt University Medical Center, Nashville, TN; School of Pharmacy (B.E.G.), University of Wisconsin, Madison; Department of Neurology (P.P.), The Royal Melbourne Hospital; Department of Medicine (P.P.), Austin Health, The University of Melbourne; and Bladin-Berkovic Comprehensive Epilepsy Program (P.P.), Department of Neurology, Austin Health, Heidelberg, Australia., Klein P; From the Department of Neuroscience (S.N.B., Z.C., P.P.), Central Clinical School, and Clinical Epidemiology (Z.C.), School of Public Health and Preventive Medicine, Monash University; Department of Neurology (S.N.B., Z.C., P.P.), Alfred Health, Melbourne, Australia; Department of Neurology (S.N.B., J.F.), New York University Grossman School of Medicine, New York; Department of Neurology (A.M.K.), University of Miami, Miller School of Medicine, FL; Department of Neurology (M.G.H.), Westchester Medical Center Health, Valhalla, NY; Mid-Atlantic Epilepsy and Sleep Center (P.K.), Bethesda, MD; Department of Neurology (P.K.), The George Washington University, DC; Department of Neurology (B.W.A.-K.), Vanderbilt University Medical Center, Nashville, TN; School of Pharmacy (B.E.G.), University of Wisconsin, Madison; Department of Neurology (P.P.), The Royal Melbourne Hospital; Department of Medicine (P.P.), Austin Health, The University of Melbourne; and Bladin-Berkovic Comprehensive Epilepsy Program (P.P.), Department of Neurology, Austin Health, Heidelberg, Australia., Abou-Khalil BW; From the Department of Neuroscience (S.N.B., Z.C., P.P.), Central Clinical School, and Clinical Epidemiology (Z.C.), School of Public Health and Preventive Medicine, Monash University; Department of Neurology (S.N.B., Z.C., P.P.), Alfred Health, Melbourne, Australia; Department of Neurology (S.N.B., J.F.), New York University Grossman School of Medicine, New York; Department of Neurology (A.M.K.), University of Miami, Miller School of Medicine, FL; Department of Neurology (M.G.H.), Westchester Medical Center Health, Valhalla, NY; Mid-Atlantic Epilepsy and Sleep Center (P.K.), Bethesda, MD; Department of Neurology (P.K.), The George Washington University, DC; Department of Neurology (B.W.A.-K.), Vanderbilt University Medical Center, Nashville, TN; School of Pharmacy (B.E.G.), University of Wisconsin, Madison; Department of Neurology (P.P.), The Royal Melbourne Hospital; Department of Medicine (P.P.), Austin Health, The University of Melbourne; and Bladin-Berkovic Comprehensive Epilepsy Program (P.P.), Department of Neurology, Austin Health, Heidelberg, Australia., Gidal BE; From the Department of Neuroscience (S.N.B., Z.C., P.P.), Central Clinical School, and Clinical Epidemiology (Z.C.), School of Public Health and Preventive Medicine, Monash University; Department of Neurology (S.N.B., Z.C., P.P.), Alfred Health, Melbourne, Australia; Department of Neurology (S.N.B., J.F.), New York University Grossman School of Medicine, New York; Department of Neurology (A.M.K.), University of Miami, Miller School of Medicine, FL; Department of Neurology (M.G.H.), Westchester Medical Center Health, Valhalla, NY; Mid-Atlantic Epilepsy and Sleep Center (P.K.), Bethesda, MD; Department of Neurology (P.K.), The George Washington University, DC; Department of Neurology (B.W.A.-K.), Vanderbilt University Medical Center, Nashville, TN; School of Pharmacy (B.E.G.), University of Wisconsin, Madison; Department of Neurology (P.P.), The Royal Melbourne Hospital; Department of Medicine (P.P.), Austin Health, The University of Melbourne; and Bladin-Berkovic Comprehensive Epilepsy Program (P.P.), Department of Neurology, Austin Health, Heidelberg, Australia., French J; From the Department of Neuroscience (S.N.B., Z.C., P.P.), Central Clinical School, and Clinical Epidemiology (Z.C.), School of Public Health and Preventive Medicine, Monash University; Department of Neurology (S.N.B., Z.C., P.P.), Alfred Health, Melbourne, Australia; Department of Neurology (S.N.B., J.F.), New York University Grossman School of Medicine, New York; Department of Neurology (A.M.K.), University of Miami, Miller School of Medicine, FL; Department of Neurology (M.G.H.), Westchester Medical Center Health, Valhalla, NY; Mid-Atlantic Epilepsy and Sleep Center (P.K.), Bethesda, MD; Department of Neurology (P.K.), The George Washington University, DC; Department of Neurology (B.W.A.-K.), Vanderbilt University Medical Center, Nashville, TN; School of Pharmacy (B.E.G.), University of Wisconsin, Madison; Department of Neurology (P.P.), The Royal Melbourne Hospital; Department of Medicine (P.P.), Austin Health, The University of Melbourne; and Bladin-Berkovic Comprehensive Epilepsy Program (P.P.), Department of Neurology, Austin Health, Heidelberg, Australia., Perucca P; From the Department of Neuroscience (S.N.B., Z.C., P.P.), Central Clinical School, and Clinical Epidemiology (Z.C.), School of Public Health and Preventive Medicine, Monash University; Department of Neurology (S.N.B., Z.C., P.P.), Alfred Health, Melbourne, Australia; Department of Neurology (S.N.B., J.F.), New York University Grossman School of Medicine, New York; Department of Neurology (A.M.K.), University of Miami, Miller School of Medicine, FL; Department of Neurology (M.G.H.), Westchester Medical Center Health, Valhalla, NY; Mid-Atlantic Epilepsy and Sleep Center (P.K.), Bethesda, MD; Department of Neurology (P.K.), The George Washington University, DC; Department of Neurology (B.W.A.-K.), Vanderbilt University Medical Center, Nashville, TN; School of Pharmacy (B.E.G.), University of Wisconsin, Madison; Department of Neurology (P.P.), The Royal Melbourne Hospital; Department of Medicine (P.P.), Austin Health, The University of Melbourne; and Bladin-Berkovic Comprehensive Epilepsy Program (P.P.), Department of Neurology, Austin Health, Heidelberg, Australia.

مؤلفون مشاركون: Human Epilepsy Project; From the Department of Neuroscience (S.N.B., Z.C., P.P.), Central Clinical School, and Clinical Epidemiology (Z.C.), School of Public Health and Preventive Medicine, Monash University; Department of Neurology (S.N.B., Z.C., P.P.), Alfred Health, Melbourne, Australia; Department of Neurology (S.N.B., J.F.), New York University Grossman School of Medicine, New York; Department of Neurology (A.M.K.), University of Miami, Miller School of Medicine, FL; Department of Neurology (M.G.H.), Westchester Medical Center Health, Valhalla, NY; Mid-Atlantic Epilepsy and Sleep Center (P.K.), Bethesda, MD; Department of Neurology (P.K.), The George Washington University, DC; Department of Neurology (B.W.A.-K.), Vanderbilt University Medical Center, Nashville, TN; School of Pharmacy (B.E.G.), University of Wisconsin, Madison; Department of Neurology (P.P.), The Royal Melbourne Hospital; Department of Medicine (P.P.), Austin Health, The University of Melbourne; and Bladin-Berkovic Comprehensive Epilepsy Program (P.P.), Department of Neurology, Austin Health, Heidelberg, Australia.

المصدر: Neurology [Neurology] 2024 Oct 08; Vol. 103 (7), pp. e209821. Date of Electronic Publication: 2024 Sep 13.

نوع المنشور: Journal Article; Observational Study; Multicenter Study

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0401060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1526-632X (Electronic) Linking ISSN: 00283878 NLM ISO Abbreviation: Neurology Subsets: MEDLINE

مواضيع طبية MeSH: Anticonvulsants*/adverse effects , Epilepsies, Partial*/drug therapy , Lamotrigine*/adverse effects , Lamotrigine*/therapeutic use , Levetiracetam*/adverse effects , Levetiracetam*/therapeutic use , Carbamazepine*/adverse effects , Carbamazepine*/analogs & derivatives , Carbamazepine*/therapeutic use , Oxcarbazepine*/adverse effects, Humans ; Female ; Male ; Adult ; Middle Aged ; Prospective Studies ; Young Adult

المؤلفون: Panda SK; Department of Developmental and Reproductive Toxicology, Vipragen Biosciences Private Limited, Mysuru, Karnataka, India. Electronic address: subhamstps@gmail.com., H M NK; Department of Developmental and Reproductive Toxicology, Vipragen Biosciences Private Limited, Mysuru, Karnataka, India., Takawale P; Department of Developmental and Reproductive Toxicology, Vipragen Biosciences Private Limited, Mysuru, Karnataka, India.

المصدر: Reproductive toxicology (Elmsford, N.Y.) [Reprod Toxicol] 2024 Oct; Vol. 129, pp. 108665. Date of Electronic Publication: 2024 Jul 14.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Pergamon In Cooperation With The Reproductive Toxicology Center Country of Publication: United States NLM ID: 8803591 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-1708 (Electronic) Linking ISSN: 08906238 NLM ISO Abbreviation: Reprod Toxicol Subsets: MEDLINE

مواضيع طبية MeSH: Carbamazepine*/toxicity , Rats, Wistar* , Anticonvulsants*/toxicity, Animals ; Female ; Pregnancy ; Administration, Oral ; Fetal Development/drug effects ; Abnormalities, Drug-Induced ; Maternal-Fetal Exchange ; Male ; Embryonic Development/drug effects ; Rats

المؤلفون: Yang F; Ashland Specialty Ingredients, Wilmington, DE, USA. Electronic address: fyyang@ashland.com., Stahnke R; Ashland Specialty Ingredients, Wilmington, DE, USA., Lawal K; Ashland Specialty Ingredients, Wilmington, DE, USA., Mahnen C; Ashland Specialty Ingredients, Wilmington, DE, USA., Duffy P; Ashland Specialty Ingredients, Wilmington, DE, USA., Xu S; Ashland Specialty Ingredients, Wilmington, DE, USA., Durig T; Ashland Specialty Ingredients, Wilmington, DE, USA.

المصدر: International journal of pharmaceutics [Int J Pharm] 2024 Sep 30; Vol. 663, pp. 124556. Date of Electronic Publication: 2024 Aug 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 7804127 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3476 (Electronic) Linking ISSN: 03785173 NLM ISO Abbreviation: Int J Pharm Subsets: MEDLINE

مواضيع طبية MeSH: Polylactic Acid-Polyglycolic Acid Copolymer*/chemistry , Drug Liberation* , Dexamethasone*/chemistry , Dexamethasone*/administration & dosage , Metformin*/chemistry , Metformin*/administration & dosage , Delayed-Action Preparations*/chemistry , Solubility* , Carbamazepine*/chemistry , Carbamazepine*/administration & dosage , Hot Melt Extrusion Technology*/methods, Drug Implants/chemistry ; Polyglycolic Acid/chemistry ; Drug Carriers/chemistry ; Hot Temperature ; Lactic Acid/chemistry

المؤلفون: Camerin L; Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute for Science and Technology, Barcelona, 08028, Spain.; Networking Biomedical Center in Bioengineering, Biomaterials, and Nanomedicine (CIBER-BBN), ISCIII, Madrid, 28029, Spain.; Doctorate program in organic chemistry, University of Barcelona, Barcelona, 08028, Spain., Maleeva G; Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute for Science and Technology, Barcelona, 08028, Spain.; Networking Biomedical Center in Bioengineering, Biomaterials, and Nanomedicine (CIBER-BBN), ISCIII, Madrid, 28029, Spain., Gomila AMJ; Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute for Science and Technology, Barcelona, 08028, Spain.; Networking Biomedical Center in Bioengineering, Biomaterials, and Nanomedicine (CIBER-BBN), ISCIII, Madrid, 28029, Spain., Suárez-Pereira I; Neuropsychopharmacology & Psychobiology Research Group, Department of Neuroscience, University of Cádiz, Cádiz, 11003, Spain.; Networking Biomedical Center in Mental Health (CIBER-SAM), ISCIII, Madrid, 28029, Spain.; Institute for Research and Innovation in Biomedical Sciences of Cádiz, INiBICA, University Hospital Puerta del Mar, Cádiz, 11009, Spain., Matera C; Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute for Science and Technology, Barcelona, 08028, Spain.; Networking Biomedical Center in Bioengineering, Biomaterials, and Nanomedicine (CIBER-BBN), ISCIII, Madrid, 28029, Spain.; Department of Pharmaceutical Sciences, University of Milan, Milan, 20133, Italy., Prischich D; Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute for Science and Technology, Barcelona, 08028, Spain.; Networking Biomedical Center in Bioengineering, Biomaterials, and Nanomedicine (CIBER-BBN), ISCIII, Madrid, 28029, Spain.; Current address: Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, London, SW120BZ, United Kingdom., Opar E; Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute for Science and Technology, Barcelona, 08028, Spain.; Networking Biomedical Center in Bioengineering, Biomaterials, and Nanomedicine (CIBER-BBN), ISCIII, Madrid, 28029, Spain., Riefolo F; Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute for Science and Technology, Barcelona, 08028, Spain.; Networking Biomedical Center in Bioengineering, Biomaterials, and Nanomedicine (CIBER-BBN), ISCIII, Madrid, 28029, Spain.; Current address: Teamit Institute, Partnerships, Barcelona Health Hub, Barcelona, 08025, Spain., Berrocoso E; Neuropsychopharmacology & Psychobiology Research Group, Department of Neuroscience, University of Cádiz, Cádiz, 11003, Spain.; Networking Biomedical Center in Mental Health (CIBER-SAM), ISCIII, Madrid, 28029, Spain.; Institute for Research and Innovation in Biomedical Sciences of Cádiz, INiBICA, University Hospital Puerta del Mar, Cádiz, 11009, Spain., Gorostiza P; Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute for Science and Technology, Barcelona, 08028, Spain.; Networking Biomedical Center in Bioengineering, Biomaterials, and Nanomedicine (CIBER-BBN), ISCIII, Madrid, 28029, Spain.; Catalan Institution of Research and Advanced Studies (ICREA), Barcelona, 08010, Spain.

المصدر: Angewandte Chemie (International ed. in English) [Angew Chem Int Ed Engl] 2024 Sep 16; Vol. 63 (38), pp. e202403636. Date of Electronic Publication: 2024 Aug 14.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 0370543 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-3773 (Electronic) Linking ISSN: 14337851 NLM ISO Abbreviation: Angew Chem Int Ed Engl Subsets: MEDLINE

مواضيع طبية MeSH: Carbamazepine*/chemistry , Carbamazepine*/pharmacology , Zebrafish* , Anticonvulsants*/chemistry , Anticonvulsants*/pharmacology, Animals ; Light ; Molecular Structure ; Photochemical Processes ; Rats